Indefinite Delivery Contract SPE2DR25D2204

The federal contract IDV award SPE2DR25D2204 is a single-award Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers. The $999,999,999 contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain and covers a broad range of pharmaceutical products, including brand-name and generic drugs, specialty medications, vaccines, syringes, vials, and medical supplies across multiple therapeutic areas. The IDC serves as a primary vehicle for delivering these critical medical commodities to support military healthcare programs, veterans' healthcare, and other federal beneficiaries globally.

The contract originated from a DLA Troop Support Medical Supply Chain pre-solicitation for the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), which aims to establish multiple Prime Vendor Contracts to provide worldwide pharmaceutical support. The unrestricted, fully competitive solicitation will result in at least three different contractors being awarded regional contracts, with the intention of increasing the DoD's resiliency and access to vital pharmaceuticals during contingencies or natural disasters. The contract has a 30-month base period with three 30-month option periods, for a total estimated value of $30.3 billion across all regions.